Search results (190)
« Back to NewsDNA-damaging formaldehyde accelerates blood ageing by extinction of stem cells
23 March 2026
Researchers from the University of Oxford, the German Cancer Research Center, and Hospital Saint-Louis have uncovered a surprising new way that blood stem cells are lost over time, offering fresh insight into ageing and diseases that affect blood production.
Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
23 March 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.
New study reveals how blood cell production responds to parasite infection
11 March 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
New bone marrow model offers scalable platform for next-generation drug discovery
23 February 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.
2025 RDM Graduate Prize winner
15 January 2026
Congratulations to Lauren Murphy, who has been awarded the 2025 Graduate Prize from the Radcliffe Department of Medicine.
Sarah Gooding named NIHR Oxford Senior Research Fellow
14 January 2026
Congratulations to Dr Sarah Gooding, who is one of eight mid-career researchers appointed as the next cohort of NIHR Oxford BRC Senior Research Fellows.
MRC WIMM Sustainability Team recognised at LEAF Oxford Forum
12 January 2026
Congratulations to the Sustainability Committee and Working Group, who received an award for ‘Community and Culture’ at the LEAF Oxford Forum 2025.
Holly Russell receives Lee Placito Research Fellowship
9 December 2025
Congratulations to Holly Russell who has been awarded a fellowship from the Lee Placito Medical Fund.
Study reveals how drug resistance develops early in targeted AML therapy
17 November 2025
A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.
Oxford scientists capture genome’s structure in unprecedented detail
5 November 2025
RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Abdullah Khan receives Wellcome Career Development Award
4 November 2025
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
MRC WIMM researchers receive full Professor title
1 October 2025
James Davies and Bethan Psaila have been awarded the title of Full Professor in the University’s 2025 Recognition of Distinction exercise.
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.